Colorectal Cancer,Gastrointestinal Cancer Encorafenib and Cetuximab Combo Therapy in BRAFV600E-Mutated mCRC: Phase 3 AE Study Mar 10, 2023
Colorectal Cancer,Gastrointestinal Cancer CAIRO5 Phase 3 Study: Ultra-Deep Sequencing for Treatment Response in Metastatic Colorectal Cancer Mar 10, 2023
Colorectal Cancer,Gastrointestinal Cancer PARADIGM Trial: MFOLFOX6+PAN Improves OS in Left-Sided McRc Mar 10, 2023
Colorectal Cancer,Gastrointestinal Cancer HER2 Scoring in Colorectal Cancer: Insights from MOUNTAINEER Trial Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer Cabozantinib and Durvalumab Combo Shows Promise for GI Malignancies: CAMILLA Trial Mar 10, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Adjuvant Olaparib Improves OS in High-Risk EBC: OlympiA Phase III Mar 09, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) A Phase 3 ASCENT Study on Sacituzumab Govitecan in mTNBC and HRQoL Mar 09, 2023
Breast Cancer,HER2- A Phase 3 Study Analyzing PBO+ET in Advanced HR+ Breast Cancer Subgroups Mar 07, 2023
